- Department of Pancreatic Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, P. R. China;
Citation: Abuduhelili. Abudula, HE Tieying. Research progress on adverse effects of perioperative red blood cell transfusion on patients after pancreaticoduodenectomy. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2022, 29(7): 971-975. doi: 10.7507/1007-9424.202110083 Copy
1. | Leichtle SW, Kaoutzanis C, Mouawad NJ, et al. Classic Whipple versus pylorus-preserving pancreaticoduodenectomy in the ACS NSQIP. J Surg Res, 2013, 183(1): 170-176. |
2. | Pędziwiatr M, Małczak P, Pisarska M, et al. Minimally invasive versus open pancreatoduodenectomy—systematic review and meta-analysis. Langenbecks Arch Surg, 2017, 402(5): 841-851. |
3. | Swanson RS, Pezzi CM, Mallin K, et al. The 90-day mortality after pancreatectomy for cancer is double the 30-day mortality: more than 20 000 resections from the National Cancer Data Base. Ann Surg Oncol, 2014, 21(13): 4059-4067. |
4. | Remy KE, Hall MW, Cholette J, et al. Mechanisms of red blood cell transfusion-related immunomodulation. Transfusion, 2018, 58(3): 804-815. |
5. | Gascón P, Zoumbos NC, Young NS. Immunologic abnormalities in patients receiving multiple blood transfusions. Ann Intern Med, 1984, 100(2): 173-177. |
6. | Kaplan J, Sarnaik S, Gitlin J, et al. Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood, 1984, 64(1): 308-310. |
7. | Youssef LA, Spitalnik SL. Transfusion-related immunomodulation: a reappraisal. Curr Opin Hematol, 2017, 24(6): 551-557. |
8. | Rohde JM, Dimcheff DE, Blumberg N, et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA, 2014, 311(13): 1317-1326. |
9. | Burrows L, Tartter P. Effect of blood transfusions on colonic malignancy recurrent rate. Lancet, 1982, 2(8299): 662. doi: 10.1016/s0140-6736(82)92764-7. |
10. | Sun C, Wang Y, Yao HS, et al. Allogeneic blood transfusion and the prognosis of gastric cancer patients: systematic review and meta-analysis. Int J Surg, 2015, 13: 102-110. |
11. | Althoff FC, Neb H, Herrmann E, et al. Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis. Ann Surg, 2019, 269(5): 794-804. |
12. | Seykora TF, Ecker BL, McMillan MT, et al. The beneficial effects of minimizing blood loss in pancreatoduodenectomy. Ann Surg, 2019, 270(1): 147-157. |
13. | 王贺彬, 熊光冰, 朱峰, 等. 腹腔镜胰十二指肠切除术后并发症的Clavien-Dindo分级及影响因素分析. 中华外科杂志, 2018, 56(11): 828-832. |
14. | 古力帕日·克力木, 张蕾. 输血对胃癌手术患者预后影响的meta分析. 中国医药导报, 2020, 17(7): 98-101, 105. |
15. | 高铭, 戴刚, 蔡卓玮, 等. 结直肠癌术后并发症的风险预测模型. 中国普外基础与临床杂志, 2021, 28(2): 252-255. |
16. | Wu HL, Tai YH, Lin SP, et al. The impact of blood transfusion on recurrence and mortality following colorectal cancer resection: a propensity score analysis of 4 030 patients. Sci Rep, 2018, 8(1): 13345. doi: 10.1038/s41598-018-31662-5. |
17. | Xun Y, Tian H, Hu L, et al. The impact of perioperative allogeneic blood transfusion on prognosis of hepatocellular carcinoma after radical hepatectomy: a systematic review and meta-analysis of cohort studies. Medicine (Baltimore), 2018, 97(43): e12911. doi: 10.1097/MD.0000000000012911. |
18. | Bennett S, Baker LK, Martel G, et al. The impact of perioperative red blood cell transfusions in patients undergoing liver resection: a systematic review. HPB (Oxford), 2017, 19(4): 321-330. |
19. | Park HM, Park SJ, Shim JR, et al. Perioperative transfusion in pancreatoduodenectomy: the double-edged sword of pancreatic surgeons. Medicine (Baltimore), 2017, 96(49): e9019. doi: 10.1097/MD.0000000000009019. |
20. | Lucas DJ, Schexneider KI, Weiss M, et al. Trends and risk factors for transfusion in hepatopancreatobiliary surgery. J Gastrointest Surg, 2014, 18(4): 719-728. |
21. | Ejaz A, Spolverato G, Kim Y, et al. Impact of blood transfusions and transfusion practices on long-term outcome following hepatopancreaticobiliary surgery. J Gastrointest Surg, 2015, 19(5): 887-896. |
22. | Ellingson KD, Sapiano MRP, Haass KA, et al. Continued decline in blood collection and transfusion in the United States-2015. Transfusion, 2017, 57 Suppl 2(Suppl 2): 1588-1598. |
23. | Musallam KM, Tamim HM, Richards T, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet, 2011, 378(9800): 1396-1407. |
24. | 连天立. 梗阻性黄疸对胰十二指肠切除术围术期凝血功能及并发症的影响. 兰州: 兰州大学, 2018. |
25. | Peters JH, Carey LC. Historical review of pancreaticoduodenectomy. Am J Surg, 1991, 161(2): 219-225. |
26. | Abe T, Amano H, Hanada K, et al. Perioperative red blood cell transfusion is associated with poor long-term survival in pancreatic adenocarcinoma. Anticancer Res, 2017, 37(10): 5863-5870. |
27. | Sutton JM, Kooby DA, Wilson GC, et al. Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study. J Gastrointest Surg, 2014, 18(9): 1575-1587. |
28. | Kim SY, Choi M, Hwang HK, et al. Intraoperative transfusion is independently associated with a worse prognosis in resected pancreatic cancer—a retrospective cohort analysis. J Clin Med, 2020, 9(3): 689. doi: 10.3390/jcm9030689. |
29. | Kneuertz PJ, Patel SH, Chu CK, et al. Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma. Ann Surg Oncol, 2011, 18(5): 1327-1334. |
30. | Oehme F, Hempel S, Knote R, et al. Perioperative blood management of preoperative anemia determines long-term outcome in patients with pancreatic surgery. J Gastrointest Surg, 2021, 25(10): 2572-2581. |
31. | Hüttner FJ, Fitzmaurice C, Schwarzer G, et al. Pylorus-preserving pancreaticoduodenectomy (PP Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev, 2016, 2(2): CD006053. doi: 10.1002/14651858.CD006053. |
32. | Hwang HK, Jung MJ, Lee SH, et al. Adverse oncologic effects of intraoperative transfusion during pancreatectomy for left-sided pancreatic cancer: the need for strict transfusion policy. J Hepatobiliary Pancreat Sci, 2016, 23(8): 497-507. |
33. | Kamarajah SK, Bundred J, Marc OS, et al. Robotic versus conventional laparoscopic pancreaticoduodenectomy a systematic review and meta-analysis. Eur J Surg Oncol, 2020, 46(1): 6-14. |
34. | Ross A, Mohammed S, Vanburen G, et al. An assessment of the necessity of transfusion during pancreatoduodenectomy. Surgery, 2013, 154(3): 504-511. |
35. | Klompmaker S, van Hilst J, Wellner UF, et al. Outcomes after minimally-invasive versus open pancreatoduodenectomy: a Pan-European propensity score matched study. Ann Surg, 2020, 271(2): 356-363. |
36. | Watanabe Y, Nishihara K, Matsumoto S, et al. Effect of postoperative major complications on prognosis after pancreatectomy for pancreatic cancer: a retrospective review. Surg Today, 2017, 47(5): 555-567. |
37. | Dhayat SA, Tamim ANJ, Jacob M, et al. Postoperative pancreatic fistula affects recurrence-free survival of pancreatic cancer patients. PLoS One, 2021, 16(6): e0252727. doi: 10.1371/journal.pone.0252727. |
38. | Bansal SS, Hodson J, Khalil K, et al. Distinct risk factors for early and late blood transfusion following pancreaticoduodenectomy. Hepatobiliary Pancreat Dis Int, 2018, 17(4): 349-357. |
39. | Lyu Y, Cheng Y, Wang B, et al. Minimally invasive versus open pancreaticoduodenectomy: an up-to-date meta-analysis of comparative cohort studies. J Laparoendosc Adv Surg Tech A, 2019, 29(4): 449-457. |
40. | Nickel F, Haney CM, Kowalewski KF, et al. Laparoscopic versus open pancreaticoduodenectomy: a systematic review and meta-analysis of randomized controlled trials. Ann Surg, 2020, 271(1): 54-66. |
41. | Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery, 2017, 161(3): 584-591. |
42. | Zhang L, Liao Q, Zhang T, et al. Blood transfusion is an independent risk factor for postoperative serious infectious complications after pancreaticoduodenectomy. World J Surg, 2016, 40(10): 2507-2512. |
43. | Neoptolemos JP, Stocken DD, Bassi C, et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA, 2010, 304(10): 1073-1081. |
44. | Tartter PI. Blood transfusion and infectious complications following colorectal cancer surgery. Br J Surg, 1988, 75(8): 789-792. |
45. | Dosch AR, Grigorian A, Delaplain PT, et al. Perioperative blood transfusion is associated with an increased risk for post-surgical infection following pancreaticoduodenectomy. HPB (Oxford), 2019, 21(11): 1577-1584. |
46. | Benson D, Barnett CC. Perioperative blood transfusions promote pancreas cancer progression. J Surg Res, 2011, 166(2): 275-279. |
47. | Lo KK, Bey EA, Patra B, et al. Hemoglobin-based oxygen carrier mitigates transfusion-mediated pancreas cancer progression. Ann Surg Oncol, 2013, 20(6): 2073-2077. |
48. | Mavros MN, Xu L, Maqsood H, et al. Perioperative blood transfusion and the prognosis of pancreatic cancer surgery: systematic review and meta-analysis. Ann Surg Oncol, 2015, 22(13): 4382-4391. |
49. | Wang Q, Du T, Lu C. Perioperative blood transfusion and the clinical outcomes of patients undergoing cholangiocarcinoma surgery: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol, 2016, 28(11): 1233-1240. |
50. | Ye L, Livingston EH, Myers B, et al. The effect of perioperative blood transfusion on long-term survival outcomes after surgery for pancreatic ductal adenocarcinoma: a systematic review. Pancreas, 2021, 50(5): 648-656. |
51. | Baker L, Park L, Gilbert R, et al. Intraoperative red blood cell transfusion decision-making: a systematic review of guidelines. Ann Surg, 2021, 274(1): 86-96. |
52. | Carson JL, Stanworth SJ, Roubinian N, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev, 2016, 10(10): CD002042. doi: 10.1002/14651858.CD002042. |
53. | Tomimaru Y, Noguchi K, Dono K. Necessity for autologous blood storage and transfusion in patients undergoing pancreatoduodenectomy. Surg Today, 2017, 47(5): 568-574. |
54. | Bennett S, Tinmouth A, McIsaac DI, et al. Ottawa criteria for appropriate transfusions in hepatectomy: using the RAND/UCLA appropriateness method. Ann Surg, 2018, 267(4): 766-774. |
55. | Nordestgaard AT, Rasmussen LS, Sillesen M, et al. Red blood cell transfusion in surgery: an observational study of the trends in the USA from 2011 to 2016. Anaesthesia, 2020, 75(4): 455-463. |
56. | Kautza BC, Cohen MJ, Cuschieri J, et al. Changes in massive transfusion over time: an early shift in the right direction? J Trauma Acute Care Surg, 2012, 72(1): 106-111. |
57. | Guerado E, Medina A, Mata MI, et al. Protocols for massive blood transfusion: when and why, and potential complications. Eur J Trauma Emerg Surg, 2016, 42(3): 283-295. |
58. | Jeon YB, Yun S, Ok SY, et al. Impact of a transfusion-free program on patients undergoing pancreaticoduodenectomy. Am Surg, 2016, 82(2): 140-145. |
- 1. Leichtle SW, Kaoutzanis C, Mouawad NJ, et al. Classic Whipple versus pylorus-preserving pancreaticoduodenectomy in the ACS NSQIP. J Surg Res, 2013, 183(1): 170-176.
- 2. Pędziwiatr M, Małczak P, Pisarska M, et al. Minimally invasive versus open pancreatoduodenectomy—systematic review and meta-analysis. Langenbecks Arch Surg, 2017, 402(5): 841-851.
- 3. Swanson RS, Pezzi CM, Mallin K, et al. The 90-day mortality after pancreatectomy for cancer is double the 30-day mortality: more than 20 000 resections from the National Cancer Data Base. Ann Surg Oncol, 2014, 21(13): 4059-4067.
- 4. Remy KE, Hall MW, Cholette J, et al. Mechanisms of red blood cell transfusion-related immunomodulation. Transfusion, 2018, 58(3): 804-815.
- 5. Gascón P, Zoumbos NC, Young NS. Immunologic abnormalities in patients receiving multiple blood transfusions. Ann Intern Med, 1984, 100(2): 173-177.
- 6. Kaplan J, Sarnaik S, Gitlin J, et al. Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood, 1984, 64(1): 308-310.
- 7. Youssef LA, Spitalnik SL. Transfusion-related immunomodulation: a reappraisal. Curr Opin Hematol, 2017, 24(6): 551-557.
- 8. Rohde JM, Dimcheff DE, Blumberg N, et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA, 2014, 311(13): 1317-1326.
- 9. Burrows L, Tartter P. Effect of blood transfusions on colonic malignancy recurrent rate. Lancet, 1982, 2(8299): 662. doi: 10.1016/s0140-6736(82)92764-7.
- 10. Sun C, Wang Y, Yao HS, et al. Allogeneic blood transfusion and the prognosis of gastric cancer patients: systematic review and meta-analysis. Int J Surg, 2015, 13: 102-110.
- 11. Althoff FC, Neb H, Herrmann E, et al. Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis. Ann Surg, 2019, 269(5): 794-804.
- 12. Seykora TF, Ecker BL, McMillan MT, et al. The beneficial effects of minimizing blood loss in pancreatoduodenectomy. Ann Surg, 2019, 270(1): 147-157.
- 13. 王贺彬, 熊光冰, 朱峰, 等. 腹腔镜胰十二指肠切除术后并发症的Clavien-Dindo分级及影响因素分析. 中华外科杂志, 2018, 56(11): 828-832.
- 14. 古力帕日·克力木, 张蕾. 输血对胃癌手术患者预后影响的meta分析. 中国医药导报, 2020, 17(7): 98-101, 105.
- 15. 高铭, 戴刚, 蔡卓玮, 等. 结直肠癌术后并发症的风险预测模型. 中国普外基础与临床杂志, 2021, 28(2): 252-255.
- 16. Wu HL, Tai YH, Lin SP, et al. The impact of blood transfusion on recurrence and mortality following colorectal cancer resection: a propensity score analysis of 4 030 patients. Sci Rep, 2018, 8(1): 13345. doi: 10.1038/s41598-018-31662-5.
- 17. Xun Y, Tian H, Hu L, et al. The impact of perioperative allogeneic blood transfusion on prognosis of hepatocellular carcinoma after radical hepatectomy: a systematic review and meta-analysis of cohort studies. Medicine (Baltimore), 2018, 97(43): e12911. doi: 10.1097/MD.0000000000012911.
- 18. Bennett S, Baker LK, Martel G, et al. The impact of perioperative red blood cell transfusions in patients undergoing liver resection: a systematic review. HPB (Oxford), 2017, 19(4): 321-330.
- 19. Park HM, Park SJ, Shim JR, et al. Perioperative transfusion in pancreatoduodenectomy: the double-edged sword of pancreatic surgeons. Medicine (Baltimore), 2017, 96(49): e9019. doi: 10.1097/MD.0000000000009019.
- 20. Lucas DJ, Schexneider KI, Weiss M, et al. Trends and risk factors for transfusion in hepatopancreatobiliary surgery. J Gastrointest Surg, 2014, 18(4): 719-728.
- 21. Ejaz A, Spolverato G, Kim Y, et al. Impact of blood transfusions and transfusion practices on long-term outcome following hepatopancreaticobiliary surgery. J Gastrointest Surg, 2015, 19(5): 887-896.
- 22. Ellingson KD, Sapiano MRP, Haass KA, et al. Continued decline in blood collection and transfusion in the United States-2015. Transfusion, 2017, 57 Suppl 2(Suppl 2): 1588-1598.
- 23. Musallam KM, Tamim HM, Richards T, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet, 2011, 378(9800): 1396-1407.
- 24. 连天立. 梗阻性黄疸对胰十二指肠切除术围术期凝血功能及并发症的影响. 兰州: 兰州大学, 2018.
- 25. Peters JH, Carey LC. Historical review of pancreaticoduodenectomy. Am J Surg, 1991, 161(2): 219-225.
- 26. Abe T, Amano H, Hanada K, et al. Perioperative red blood cell transfusion is associated with poor long-term survival in pancreatic adenocarcinoma. Anticancer Res, 2017, 37(10): 5863-5870.
- 27. Sutton JM, Kooby DA, Wilson GC, et al. Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study. J Gastrointest Surg, 2014, 18(9): 1575-1587.
- 28. Kim SY, Choi M, Hwang HK, et al. Intraoperative transfusion is independently associated with a worse prognosis in resected pancreatic cancer—a retrospective cohort analysis. J Clin Med, 2020, 9(3): 689. doi: 10.3390/jcm9030689.
- 29. Kneuertz PJ, Patel SH, Chu CK, et al. Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma. Ann Surg Oncol, 2011, 18(5): 1327-1334.
- 30. Oehme F, Hempel S, Knote R, et al. Perioperative blood management of preoperative anemia determines long-term outcome in patients with pancreatic surgery. J Gastrointest Surg, 2021, 25(10): 2572-2581.
- 31. Hüttner FJ, Fitzmaurice C, Schwarzer G, et al. Pylorus-preserving pancreaticoduodenectomy (PP Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev, 2016, 2(2): CD006053. doi: 10.1002/14651858.CD006053.
- 32. Hwang HK, Jung MJ, Lee SH, et al. Adverse oncologic effects of intraoperative transfusion during pancreatectomy for left-sided pancreatic cancer: the need for strict transfusion policy. J Hepatobiliary Pancreat Sci, 2016, 23(8): 497-507.
- 33. Kamarajah SK, Bundred J, Marc OS, et al. Robotic versus conventional laparoscopic pancreaticoduodenectomy a systematic review and meta-analysis. Eur J Surg Oncol, 2020, 46(1): 6-14.
- 34. Ross A, Mohammed S, Vanburen G, et al. An assessment of the necessity of transfusion during pancreatoduodenectomy. Surgery, 2013, 154(3): 504-511.
- 35. Klompmaker S, van Hilst J, Wellner UF, et al. Outcomes after minimally-invasive versus open pancreatoduodenectomy: a Pan-European propensity score matched study. Ann Surg, 2020, 271(2): 356-363.
- 36. Watanabe Y, Nishihara K, Matsumoto S, et al. Effect of postoperative major complications on prognosis after pancreatectomy for pancreatic cancer: a retrospective review. Surg Today, 2017, 47(5): 555-567.
- 37. Dhayat SA, Tamim ANJ, Jacob M, et al. Postoperative pancreatic fistula affects recurrence-free survival of pancreatic cancer patients. PLoS One, 2021, 16(6): e0252727. doi: 10.1371/journal.pone.0252727.
- 38. Bansal SS, Hodson J, Khalil K, et al. Distinct risk factors for early and late blood transfusion following pancreaticoduodenectomy. Hepatobiliary Pancreat Dis Int, 2018, 17(4): 349-357.
- 39. Lyu Y, Cheng Y, Wang B, et al. Minimally invasive versus open pancreaticoduodenectomy: an up-to-date meta-analysis of comparative cohort studies. J Laparoendosc Adv Surg Tech A, 2019, 29(4): 449-457.
- 40. Nickel F, Haney CM, Kowalewski KF, et al. Laparoscopic versus open pancreaticoduodenectomy: a systematic review and meta-analysis of randomized controlled trials. Ann Surg, 2020, 271(1): 54-66.
- 41. Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery, 2017, 161(3): 584-591.
- 42. Zhang L, Liao Q, Zhang T, et al. Blood transfusion is an independent risk factor for postoperative serious infectious complications after pancreaticoduodenectomy. World J Surg, 2016, 40(10): 2507-2512.
- 43. Neoptolemos JP, Stocken DD, Bassi C, et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA, 2010, 304(10): 1073-1081.
- 44. Tartter PI. Blood transfusion and infectious complications following colorectal cancer surgery. Br J Surg, 1988, 75(8): 789-792.
- 45. Dosch AR, Grigorian A, Delaplain PT, et al. Perioperative blood transfusion is associated with an increased risk for post-surgical infection following pancreaticoduodenectomy. HPB (Oxford), 2019, 21(11): 1577-1584.
- 46. Benson D, Barnett CC. Perioperative blood transfusions promote pancreas cancer progression. J Surg Res, 2011, 166(2): 275-279.
- 47. Lo KK, Bey EA, Patra B, et al. Hemoglobin-based oxygen carrier mitigates transfusion-mediated pancreas cancer progression. Ann Surg Oncol, 2013, 20(6): 2073-2077.
- 48. Mavros MN, Xu L, Maqsood H, et al. Perioperative blood transfusion and the prognosis of pancreatic cancer surgery: systematic review and meta-analysis. Ann Surg Oncol, 2015, 22(13): 4382-4391.
- 49. Wang Q, Du T, Lu C. Perioperative blood transfusion and the clinical outcomes of patients undergoing cholangiocarcinoma surgery: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol, 2016, 28(11): 1233-1240.
- 50. Ye L, Livingston EH, Myers B, et al. The effect of perioperative blood transfusion on long-term survival outcomes after surgery for pancreatic ductal adenocarcinoma: a systematic review. Pancreas, 2021, 50(5): 648-656.
- 51. Baker L, Park L, Gilbert R, et al. Intraoperative red blood cell transfusion decision-making: a systematic review of guidelines. Ann Surg, 2021, 274(1): 86-96.
- 52. Carson JL, Stanworth SJ, Roubinian N, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev, 2016, 10(10): CD002042. doi: 10.1002/14651858.CD002042.
- 53. Tomimaru Y, Noguchi K, Dono K. Necessity for autologous blood storage and transfusion in patients undergoing pancreatoduodenectomy. Surg Today, 2017, 47(5): 568-574.
- 54. Bennett S, Tinmouth A, McIsaac DI, et al. Ottawa criteria for appropriate transfusions in hepatectomy: using the RAND/UCLA appropriateness method. Ann Surg, 2018, 267(4): 766-774.
- 55. Nordestgaard AT, Rasmussen LS, Sillesen M, et al. Red blood cell transfusion in surgery: an observational study of the trends in the USA from 2011 to 2016. Anaesthesia, 2020, 75(4): 455-463.
- 56. Kautza BC, Cohen MJ, Cuschieri J, et al. Changes in massive transfusion over time: an early shift in the right direction? J Trauma Acute Care Surg, 2012, 72(1): 106-111.
- 57. Guerado E, Medina A, Mata MI, et al. Protocols for massive blood transfusion: when and why, and potential complications. Eur J Trauma Emerg Surg, 2016, 42(3): 283-295.
- 58. Jeon YB, Yun S, Ok SY, et al. Impact of a transfusion-free program on patients undergoing pancreaticoduodenectomy. Am Surg, 2016, 82(2): 140-145.